Pretreatment with Shenmai Injection Protects against Coronary Microvascular Dysfunction

BACKGROUND: The clinical treatment of coronary microvascular dysfunction (CMD) is mainly based on conventional medicine, but the mechanism of the medicine is single and the efficacy is different. Shenmai injection (SMI) has a variety of ingredients, but the effect of SMI on CMD has not been studied....

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Zhaohai, Yu, Zhangjie, Xu, Buyun, Zhou, Yan, Xing, Yangbo, Li, Qingsong, Tang, Weiliang, Peng, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203227/
https://www.ncbi.nlm.nih.gov/pubmed/35722150
http://dx.doi.org/10.1155/2022/8630480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203227/
https://www.ncbi.nlm.nih.gov/pubmed/35722150
http://dx.doi.org/10.1155/2022/8630480

Ejemplares similares